Metronidazole Gel Suppliers & Bulk Manufacturers
Available Forms: Vaginal Gel
Available Strengths: 0.75% W/W, 1%,
Reference Brands: MetroGel (USA), Rozex (EU/LATAM), Metron (India)
Category:
Anthelmintic
Metronidazole is an antibiotic. It's used to treat skin infections, rosacea and mouth infections, including infected gums and dental abscesses. It's also used to treat conditions such as bacterial vaginosis and pelvic inflammatory disease.
Metronidazole Gel is available in Vaginal Gel
and strengths such as 0.75% W/W, 1%,.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Metronidazole Gel is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Metronidazole Gel can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Metronidazole vaginal gel is a topical antimicrobial formulation used for the treatment of bacterial vaginosis (BV), a common vaginal infection caused by an imbalance of normal vaginal bacteria. It contains metronidazole, a nitroimidazole antimicrobial agent that works by inhibiting the growth of anaerobic bacteria responsible for the infection. The gel formulation allows the medication to be applied directly inside the vagina, providing targeted local action with minimal systemic absorption.
Metronidazole vaginal gel 0.75% is approved by the U.S. Food and Drug Administration as a standard treatment for bacterial vaginosis and is typically administered once daily for five days. Clinical research has also explored higher-strength formulations such as metronidazole vaginal gel 1.3%, designed to provide a shorter treatment duration while maintaining similar therapeutic effectiveness. This alternative dosing approach may improve patient convenience and treatment adherence.
Due to its proven efficacy and localized delivery, metronidazole vaginal gel is widely used in gynecological practice for the management of bacterial vaginosis and related vaginal infections.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing